We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Medication Adherence in Individuals With Epilepsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01566500
Recruitment Status : Completed
First Posted : March 29, 2012
Results First Posted : August 26, 2015
Last Update Posted : August 26, 2015
Epilepsy Foundation
University of Nebraska
Information provided by (Responsible Party):
Niall Bolger, Columbia University

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Condition: Epilepsy

  Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
Study Sample Adults with self-reported epilepsy.

Participant Flow:   Overall Study
    Study Sample
STARTED   140 

  Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
Adults with self-reported epilepsy.

Reporting Groups
Study Sample Adults with self-reported epilepsy.

Baseline Measures
   Study Sample 
Overall Participants Analyzed 
[Units: Participants]
[Units: Years]
Mean (Standard Deviation)
 38.51  (11.72) 
[Units: Participants]
Female   87 
Male   53 
Region of Enrollment 
[Units: Participants]
United States   140 

  Outcome Measures

1.  Primary:   Raw Count of Number of Days of Medication Nonadherence   [ Time Frame: Enrollment ]

2.  Secondary:   Score on Barriers to Medication Adherence   [ Time Frame: Enrollment ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

3.  Secondary:   Score of Psychosocial Predictors of Adherence   [ Time Frame: Enrollment ]
Results not yet reported.   Anticipated Reporting Date:   No text entered.  

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact:  
Name/Title: Marie Chesaniuk
Organization: Columbia University
phone: 212-854-0127
e-mail: mc3333@columbia.edu

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Niall Bolger, Columbia University
ClinicalTrials.gov Identifier: NCT01566500     History of Changes
Other Study ID Numbers: AAAI1597
First Submitted: March 28, 2012
First Posted: March 29, 2012
Results First Submitted: April 28, 2015
Results First Posted: August 26, 2015
Last Update Posted: August 26, 2015